Nicht lieferbar
Andere Kunden interessierten sich auch für
![Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders]( "Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders")
Exploring the Adoption of Implantable Brain Stimulation Into Standard of Care for Central Nervous System Disorders24,99 €![Novel Molecular Targets for Mood Disorders and Psychosis]( "Novel Molecular Targets for Mood Disorders and Psychosis")
Novel Molecular Targets for Mood Disorders and Psychosis47,99 €![Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders]( "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders")
Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders17,99 €![Improving Systems of Follow-Up Care for Traumatic Brain Injury]( "Improving Systems of Follow-Up Care for Traumatic Brain Injury")
Improving Systems of Follow-Up Care for Traumatic Brain Injury21,99 €![Enabling Precision Medicine]( "Enabling Precision Medicine")
Enabling Precision Medicine60,99 €
Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative disorders. Chief among the challenges that have hindered the development of therapeutics for central nervous system (CNS) disorders is the blood-brain barrier (BBB). The Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the challenges associated with the BBB that have thus far stymied development of CNS drugs, examine new technologies that could address these challenges, and highlight potential opportunities for moving the field forward. This publication summarizes the presentations and discussions from the workshop.